Related Experiment Videos
High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and
G Assmann1, H Schulte, A von Eckardstein
1Institut für Arterioskleroseforschung Universität Münster, Germany.
Insights
High-density lipoprotein cholesterol is a significant risk factor for coronary heart disease (CHD) in men over 40. This finding highlights the importance of monitoring cholesterol levels for cardiovascular health.
Area of Science:
- Cardiology
- Epidemiology
- Preventive Medicine
Background:
- Coronary heart disease (CHD) poses a significant public health challenge.
- Identifying reliable risk factors is crucial for effective prevention strategies.
Purpose of the Study:
- To assess the incidence of atherosclerotic CHD in a large cohort.
- To identify key risk factors associated with CHD development in middle-aged and older men.
Main Methods:
- Analysis of data from the Prospective Cardiovascular Münster (PROCAM) study.
- Inclusion of 4559 male participants aged 40-64 years with a 6-year follow-up.
- Univariate and multivariate analyses to determine risk factor associations.
Main Results:
- 186 participants developed atherosclerotic CHD during the follow-up period.
- Significant association found between CHD incidence and high-density lipoprotein cholesterol levels (P < 0.001).
- This association remained significant after adjusting for other known risk factors.
Conclusions:
- High-density lipoprotein cholesterol is a significant independent risk factor for atherosclerotic CHD in men aged 40-64.
- Monitoring HDL cholesterol levels is important for cardiovascular risk assessment in this demographic.
- Findings support the role of lipid management in CHD prevention.
Abstract:
The incidence of coronary heart disease (CHD) was assessed via the Prospective Cardiovascular Münster (PROCAM) study in 19,698 volunteer subjects aged between 16 and 65 years. An adequate incidence of atherosclerotic CHD was only found in male subjects greater than 40 years of age. The analysis and subsequent 6 year follow-up period was, therefore, confined to 4559 male participants aged 40-64 years. In the follow-up period, 186 study participants developed atherosclerotic CHD (134 definite non-fatal myocardial infarctions (MIs) and 52 definite atherosclerotic CHD deaths including 21 sudden cardiac deaths and 31 fatal MIs). Univariate analysis revealed a significant association between the incidence of atherosclerotic CHD and high-density lipoprotein cholesterol (P < 0.001), which remained after adjustment for other risk factors.